Global Market Study
on Herpes Marker
Testing:
Antibody/Antigen Based Kits to be the Most Attractive Segment by
Test Type During the Forecast Period 2017 – 2025
According to the latest market report published by Persistence Market Research
titled ‘Herpes Marker Testing Market: Global Industry Analysis (2012 – 2016)
& Forecast (2017 – 2025)’, the global market is expected to be valued at US$
481.8 Mn by 2025 and expand at a CAGR of 6.1% over the forecast period
(2017–2025). The overall market is anticipated to grow 1.7x in terms of value
over the forecast period.
Market Dynamics
Certain factors such as positive diagnostic lab industry dynamics, increasing
herpes prevalence, rising awareness, support from various government and nongovernment organizations, new product approvals and launches, increasing
focus on evidence based medicines etc. are boosting revenue growth of the
market. However, insufficient R&D initiatives, poor access to diagnostic
services in remote areas, pricing pressures, and stringent regulations are some
of the factors restricting growth of the market.
Browse Full Research Report:
https://www.persistencemarketresearch.com/market-research/herpes-markerstesting-market.asp
Segmental Forecast
On the basis of test type, the market has been segmented into viral culture test,
nucleic acid amplification-based kits and antibody/antigen-based kits.
Antibody/Antigen based kits is the highest revenue generating segment over the
forecast period owing to the huge product availability as well as high physician
preference for this test type. Nucleic Acid Amplification-based kits segment
will report the highest growth rate over the forecast period due to the growing
acceptance of PCR diagnosis as a gold standard test in herpes testing owing to
high sensitivity, specificity and positivity ratio for herpes diagnosis.
Antibody/Antigen based kits is projected to be the most attractive segment with
an attractiveness index of 1.5 during the forecast period.
Based on the indication, the market has been segmented into HSV-1, HSV-2
and HSV-1/ HSV-2. HSV-1/HSV-2 segment dominated the global herpes
marker testing market in revenue terms in 2016 and is projected to continue to
do so throughout the forecast period. HSV-1/HSV-2 is projected to be the most
attractive segment with an attractiveness index of 1.6 and growth rate of 6.5%
during the forecast period.
On the basis of application, the market has been segmented into research use
and clinical diagnostics segment. Clinical diagnostics application dominates the
market for herpes marker testing with a value share in excess of 85%
throughout the forecast period.
Request and Download Sample Report@
https://www.persistencemarketresearch.com/samples/4185
Based on end user, the market has been segmented into hospitals, diagnostics
centers, clinics and academic & research institutes. Among all the end users,
most of the revenue is generated via the diagnostic centers sales followed by
hospitals owing to the maximum number of tests being performed at these
facilities. Diagnostics centers dominated the global herpes marker testing
market in revenue terms in 2016 and is projected to continue to do so
throughout the forecast period. This segment represents a market attractiveness
index of 1.6 over the forecast period.
Among the regional markets, North America holds the maximum value share
in the global market owing to the accessibility and affordability of diagnostic
services in the region and a favorable reimbursement scenario. In terms of
growth rate, North America leads with a CAGR of 6.4% followed by Asia
Pacific with a CAGR of 6.3%. Asia Pacific represents a highly potential market
with a significant growth rate owing to the increasing awareness as well as
increasing penetration of market players in the region. The market in Europe
ranks third in terms of global market size as well as growth rate while Latin
America represents the least market attractiveness index over the forecast
period.
Vendor Insights
Leading players operating in the global herpes marker testing market covered in
the report include Abbott Laboratories, Abcam Plc, BioMérieux SA, Thermo
Fisher Scientific, Inc., F. Hoffmann-La Roche Ltd., DiaSorin S.p.A., Quidel
Corporation, Luminex Corporation, Merck KGaA, Qiagen N.V., Norgen Biotek
Corp., Hologic Inc., Bio Rad Laboratories Inc., Meridian Bioscience Inc. and
Teco Diagnostics.
Buy Full Herpes Marker Testing Market Report
@ https://www.persistencemarketresearch.com/checkout/4185
About Us
Persistence Market Research (PMR) is a third-platform research firm. Our
research model is a unique collaboration of data analytics and market research
methodology to help businesses achieve optimal performance.
To support companies in overcoming complex business challenges, we follow a
multi-disciplinary approach. At PMR, we unite various data streams from
multi-dimensional sources. By deploying real-time data collection, big data, and
customer experience analytics, we deliver business intelligence for
organizations of all sizes.
Contact Us
Persistence Market Research
305 Broadway
7th Floor, New York City,
NY 10007, United States,
USA – Canada Toll Free: 800-961-0353
Email: [email protected]
Web: http://www.persistencemarketresearch.com